Improving Walking After Spinal Cord Injury
Engaging Reticulospinal Inputs to Improve Walking Ability in Humans With Spinal Cord Injury
2 other identifiers
interventional
20
1 country
1
Brief Summary
Locomotor recovery is one of the most important goals of individuals with spinal cord injury (SCI). Ambulatory deficits severely impact daily functions resulting in lower quality of life for people living with paralysis due to SCI. Although studies have shown that locomotor training improves locomotor function in people with chronic SCI, the benefits remain limited. Our overall hypothesis is that we can engage additional descending motor pathways, such as the reticulospinal tract (RST), to improve locomotor function in humans with chronic incomplete SCI. In this study we propose to test the effects of a novel intervention that uses repeated paired loud auditory and electrical stimulation of muscle afferents combined with locomotor training on walking speed and voluntary muscle strength.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2025
CompletedFirst Posted
Study publicly available on registry
November 3, 2025
CompletedStudy Start
First participant enrolled
November 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
ExpectedNovember 3, 2025
October 1, 2025
5 months
October 27, 2025
October 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
10-meter walk test (10MWT)
This standardized test assesses walking speed in meters per second over a short duration.
baseline and day 12
Secondary Outcomes (6)
Motor Evoked Potentials conditioned with Startle (MEP-LAS)
Baseline and day 12
Maximum Voluntary Contraction (MVC)
Baseline and day 12
Maximal motor response (M-max)
Baseline and day 12
StartReact response
Baseline and day 12
Spasticity
Baseline and day 12
- +1 more secondary outcomes
Study Arms (2)
Locomotor training + PAS
EXPERIMENTALThis intervention uses repeated paired loud auditory and electrical stimulation of muscle afferents combined with locomotor training. Participants will exercise walking on a treadmill with body weight support as needed for 30 minutes a day at a moderate intensity. While walking, participants will receive brief loud auditory stimuli through headphones and short electrical pulses through of electrodes positioned on two points in the leg
Locomotor training + SHAM
SHAM COMPARATORThis sham intervention uses repeated paired soft auditory clicks and electrical stimulation of muscle afferents combined with locomotor training. Participants will exercise walking on a treadmill with body weight support as needed for 30 minutes a day at a moderate intensity. While walking, participants will receive brief auditory clicks through headphones and short electrical pulses through a pair of electrodes positioned on two points in the leg.
Interventions
This new intervention consists of locomotor training in combination with paired low-intensity electrical stimulation and stimulation of the reticulospinal tract through loud sounds. Participants will receive auditory stimulation (LAS, 110dB, 500Hz, 50ms) through headphones and electrical stimulation through a pair of electrodes with 2cm inter-electrode distance positioned on the motor point over the quadriceps and the tibialis anterior muscles bilaterally. The motor point will be identified as the position of the electrodes that elicits a small visible muscle twitch or muscle contraction upon palpation over the tendon with the minimum stimulation intensity. Stimuli will be delivered with a pulse duration of 200 microseconds and will be timed to arrive at the level of the brainstem \~7ms before auditory signals.
Participants will walk on a treadmill with body-weight support (ZeroG, Aretech) in the range 0-70% as needed to prevent excessive knee flexion during stance phase or toe dragging during swing phase (Finch et al. 1991). Each session will last approximately 60-min and the duration of the treadmill training will be timed to be 30 min. Subjects will be encouraged to walk at a self-selected speed at or above 0.1m/s. Speed and body-weight support will be adjusted to achieve a perceived exertion score of 4-5 (Moderate) in the Borg scale (Borg 1982). Subjects will be allowed to rest as needed during the training sessions.
Participants will receive brief low-intensity auditory clicks (80dB, 500Hz, 50ms) through headphones and electrical stimulation through a pair of electrodes with 2cm inter-electrode distance positioned on the motor point over the quadriceps and the tibialis anterior muscles bilaterally. The motor point will be identified as the position of the electrodes that elicits a small visible muscle twitch or muscle contraction upon palpation over the tendon with the minimum stimulation intensity. Stimuli will be delivered with a pulse duration of 200 microseconds and will be timed to arrive at the level of the brainstem \~7ms before auditory signals.
Eligibility Criteria
You may qualify if:
- History of traumatic or non-traumatic SCI ≥ 6 months
- International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) level at and above T10.
- American Spinal Injury Association AIS Grade C, or D
- Weakness in ankle dorsiflexors (LEMS\<=3) with the ability to perform a small voluntary ankle dorsiflexion (as detected by presence of voluntary EMG activity in the tibialis anterior) with at least one leg.
- Ability to tolerate standing position.
- Ability to walk at a minimum speed of 0.1 mile/hour on a treadmill with less than 70% body weight support.
- Requires use of assistive devices (KAFO, AFO, cane, walker) or body weight support for ambulation.
- Ability to complete the 10-Meter Walk Test.
You may not qualify if:
- Preceding uncontrolled medical conditions including pulmonary, cardiovascular or orthopedic disease that interfere with physical performance.
- Intolerance to physical activity.
- Severe cognitive impairment that precludes the ability to participate in any of the study procedures or give verbal consent.
- Any illness or condition that based on the research team's assessment, will compromise with the patient's ability to comply with the protocol, patient safety, or the validity of the data collected during the study.
- History of stroke resulting in sensory motor deficits.
- Pregnant women.
- Participation in a high-intensity locomotor training program in the last 6 months.
- Inability to detect somatosensory evoked potentials
- Metal implant in the head
- History of epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shirley Ryan AbilityLab
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dalia De Santis, PhD
Shirley Ryan AbilityLab
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Scientist
Study Record Dates
First Submitted
October 27, 2025
First Posted
November 3, 2025
Study Start
November 15, 2025
Primary Completion
March 30, 2026
Study Completion (Estimated)
July 30, 2026
Last Updated
November 3, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- The de-identified IPD will be shared indefinitely on DASH. The data will be available at the end of the study.
De-identified data related to Demographics, clinical outcomes and instrumental data will shared through the NICHD Data ad Specimens Hub (DASH).